Gain valuable insights into the pharmaceutical and chemical processing industries through an exclusive interview with Frederic Dietrich, Managing Director of Dec Group.
Discover the true meaning of "End-to-End" and what sets our approach apart.
In recent years, the integration of automation and artificial intelligence (AI) has revolutionized various fields, with pharmaceuticals and materials science leading the charge. Among the most innovative advancements in this domain is the concept of self-driving labs - automated research facilities designed to streamline drug discovery processes, making them faster, more efficient, and cost-effective. Automation in Drug Discovery Self-driving labs in drug discovery harness cu
May 13, 2026 - Dec Group is pleased to announce that Alconbury Weston Ltd (AWL) has officially been renamed Dec Continuous Process Ltd, marking the final step in the company’s full integration into the Group following its acquisition in 2022. The incorporation of AWL’s capabilities into the Dec Group strengthened a shared commitment to advancing continuous manufacturing and advanced processing solutions. By combining AWL’s proven process technologies with Dec’s global leaders
May 11, 2026 - We are delighted to announce the official opening of Dec Brasil, marking a significant milestone in expanding our footprint and strengthening our support capabilities across Brazil and the wider South American region. This new subsidiary reinforces our long‑term commitment to serving customers locally with greater proximity. For years, our customers in Latin America have trusted Dec for innovation and reliability. Now, with a dedicated local team, we can bring
